Beckman Coulter introduces an advanced immunoassay analyzer for enhanced laboratory performance
The DxI 9000 Access Immunoassay Analyzer provides high-throughput efficiency
15 May 2023Beckman Coulter has introduced the DxI 9000 Access Immunoassay Analyzer, which claims to offer high productivity relative to its size. The DxI 9000 analyzer has the capacity to perform up to 215 tests per hour per square meter.
The DxI 9000 Analyzer innovations address today’s speed, reliability, reproducibility, quality, and menu expansion demands. The platform has been independently verified to perform at the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) optimal level, the highest level of EFLM performance evaluation. At the same time, the novel Lumi-Phos PRO Substrate has shown the capability to develop increasingly sensitive and clinically relevant assays, ensuring the system is able to meet the healthcare needs of tomorrow.
According to Julie Sawyer Montgomery, President, Beckman Coulter Diagnostics, “The DxI 9000 Access Immunoassay Analyzer sets new expectations for immunoassay testing operational performance and ability to develop and sustain improved assay sensitivity to meet tomorrow’s analytical needs. Those in the laboratory will treasure ZeroDaily Maintenance to save them time, PrecisionVision Technology to safeguard against flawed data reports, and IntelliServe to maximize system uptime. At the same time, clinical researchers are excited about the DxI 9000 Analyzer’s capability to keep pace with increasingly sensitive testing requirements as healthcare providers and pharmaceutical companies take aim at ever more challenging diseases. An inspiring feat of technology, the DxI 9000 Analyzer is a comprehensive healthcare innovation.”
An early evaluator of the DxI 9000 Analyzer, Dr. Pamela Christudoss, Professor & Head, Department of Clinical Biochemistry, Christian Medical College, Vellore, India, noted, “Like clinical laboratories worldwide, we are running more tests than any time in our history. The innovations packed into the DxI 9000 Analyzer enabled us to improve our throughput rates and turnaround times with world-class precision. In particular, the team loved the ZeroDaily Maintenance, especially for a platform that runs 450 tests per hour.”
The Beckman Coulter newly designed remote service and diagnostics solution, DxS IntelliServe, connects with DxI 9000 Analyzers to monitor data and error trends, enabling timely, proactive system service when needed. In addition, the DxS IntelliServe solution identifies service experts to resolve issues with real-time monitoring, remote operation, and troubleshooting to maximize laboratory uptime and performance. Equally impactful, the DxS IntelliServe remote update capabilities and proactive scheduling ensures systems are always running on the most up-to-date software, reducing unplanned workflow interruptions or downtime.
The Beckman Coulter Access NT-proBNP assay measures concentrations of N-terminal pro B-type natriuretic peptide that originate in a person’s heart. High levels of natriuretic peptides can indicate heart failure. Access NT-proBNP provides rapid results in less than 11 minutes and increases accuracy in diagnosing heart failure with age-based cutoffs and disease-specific comorbidity data for improved test result interpretation.
Want the latest science news straight to your inbox? Become a SelectScience member for free today >>